Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights
June 13, 4:31 PM
Gainers Vaxart (NASDAQ:VXRT) shares increased by 146.7% to $1.85 during Thursday’s after-market session. The market value of their…

ALZN

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights
June 13, 8:07 AM
Gainers Longeveron (NASDAQ:LGVN) stock rose 30.9% to $2.37 during Thursday’s pre-market session. The company’s market cap stands at…

APYX

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights
May 31, 8:06 AM
Gainers Novo Integrated Sciences (NASDAQ:NVOS) stock moved upwards by 69.6% to $0.77 during Friday’s pre-market session. The company’s…

ADAP

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights
May 21, 12:31 PM
Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) stock increased by 84.3% to $2.34 during Tuesday’s regular session. The market value of…

AKAN

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights
April 2, 4:31 PM
Gainers OneMedNet (NASDAQ:ONMD) shares moved upwards by 75.9% to $1.39 during Tuesday’s after-market session. The market value of…

ACOR

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights
January 22, 9:05 AM
Gainers MSP Recovery (NASDAQ:LIFW) shares rose 23.1% to $1.49 during Monday’s pre-market session. The market value of their…

AEMD

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights
December 6, 5:31 PM
Gainers Reshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 17.9% to $0.31 during Wednesday’s after-market session. The market value…

APDN

Read More
2 minute read
  • Biotech
  • General
  • News

Bionomics Presents Detailed Data On The Validity And Reliability Of The Subjective Units Of Distress Scale At The 2023 American College Of Neuropsychopharmacology Annual Meeting

By Benzinga Newsdesk
December 6, 9:09 AM
A psychometric analysis concluded that Subjective Units of Distress Scale (SUDS) is a psychometrically valid, sensitive, and reliable tool for evaluation of social anxiety. SUDS will be used as the primary outcome

BNOX

Read More
2 minute read
  • Cannabis
  • FDA
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Regulations

Bionomics Meets The FDA: Lead Drug Candidate For Social Anxiety Heads To Phase 3

By Lara Goldstein
October 17, 10:28 PM
Biopharma company Bionomics Ltd.

BNOX

Read More
3 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Psyched: Steve Cohen’s New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More

By Lara Goldstein
October 6, 5:07 PM
Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares

ATAI

Posts pagination

1 2 … 8 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service